Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07576868
PHASE2/PHASE3

A Study of CP-COV03 Compared With Placebo in Participants With Dengue (Part 1) and Dengue-like Illness (Part 2)

Sponsor: Hyundai Bioscience Co., Ltd.

View on ClinicalTrials.gov

Summary

This is a randomized, double-blind, placebo-controlled Phase 2/3 study to evaluate the efficacy, safety, and antiviral activity of CP-COV03 in adult patients with dengue infection.

Official title: A Randomized, Double-blinded, Placebo-controlled Clinical Trial to Evaluate Safety and Efficacy of CP-COV03 in Dengue Patients (Part 1) / Dengue and Dengue-like Illness Patients (Part 2)

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

210

Start Date

2026-04-09

Completion Date

2027-05

Last Updated

2026-07-10

Healthy Volunteers

No

Conditions

Interventions

DRUG

CP-COV03

Oral administration

DRUG

Placebo

Oral administration

Locations (2)

The National Hospital of Tropical Diseases (NHTD)

Hanoi, Vietnam

Tien Giang Provincial General Hospital

Mỹ Tho, Vietnam